…and register to the EAN congress in Amsterdam 2017.
It is not only that you can save more than 100€ if you register now, but you will be able to cover the big five neurological diseases, as well as rare… Continue Reading
Category
Featured Slider
-
-
Executive PageFeatured Slider
President’s Page: The many faces of National Neurological Societies in Europe
November 4, 2016EAN pages strives to present one country every month to the readers of the EAN pages. We have seen presentations from Albania, Croatia, Denmark, Estonia, Finland, Georgia, and Ireland so far and I would draw your attention to these wonderful articles in our newsblog. This month we have Latvia and in December it will be Moldovia. The country where the EAN congresses take place (so far Germany and Denmark) are even presented in a series of articles covering special aspects of the development of local neurology. The top neurologists from these countries take their time to present important aspects of their country like Denmark did before the Copenhagen congress in 2016. In a series of seven articles they have presented the state of the art and research in their country concerning basic MS research, pain, dementia, clinical MS research, cerebral blood flow research, clinical neurophysiology and headache. The care structures for patients and how research is helping to develop new treatments and new innovations are outlined and one can learn from their success. Whenever I read their presentations it reminds me to the rich history of neurology in Europe. All the different countries were able to show their particular contribution to the field and the achievements they have reached to provide better patient care. -
Latvia - officially the Republic of Latvia (Latvian: Latvijas Republika), is a beautiful country in the Baltic region of Northern Europe, one of the three Baltic states. The name “Latvia” comes from the ancient Latgalians, one of four Indo-European Baltic tribes who formed the core of modern Latvians. With a coastline of 531km along the Baltic Sea, Latvia is bordered by Estonia, Lithuania, Russia, and Belarus, and has 64,589 km2 of scenic plains and rivers, lakes and hills, including a majestic coastline.
-
InterviewsFeatured Slider
Interview with Prof. Claudia Sommer, Chair EAN Teaching Course sub-Committee
November 1, 2016David B. Vodušek (DV): As a senior experienced European neurologist, can you illustrate the role you give to EAN within the community of European Neurologists? Claudia Sommer (CS): The EAN is the umbrella society for the community of European Neurologists, and I am more than glad that after many years, we have achieved to build one strong society. -
Paper of the MonthFeatured Slider
Paper of the month: Improved prognosis of multiple sclerosis in the last 10 years
November 1, 2016For November 2016 we have selected: Cree BAC, Gourraud P-A, Oksenberg JR, et al. Long-term evolution of multiple sclerosis disability in the treatment era. Ann Neurol 2016:80;499-510. Studies describing the natural history of multiple sclerosis (MS) before the availability of disease-modifying treatments have reported a progression of the disease from the relapsing-remitting form to the secondary progressive form in about 50% of patients at 19 years after the onset. -
Ireland: island of saints and scholars. Although in the interests of full disclosure not all of its 5 million inhabitants are necessarily either saintly or scholarly, the visitor to its shores will certainly find many footprints of Ireland’s tradition of folklore and stories. The island’s temperate climate is nourished by the Gulf Stream, turning the landscape into a lush green onto which are embedded imprints of Ireland’s cultural past, typified by the extraordinary Neolithic tomb at Newgrange.
-
Executive PageFeatured Slider
President’s Page: Treatment of neurodegenerative diseases: are we close to a breakthrough?
October 1, 2016It is a dream of neurologists to cure degenerative diseases. The big brothers, Alzheimer’s and Parkinson’s disease have always been a huge burden of the population but are now, in the millennium of increasing population age becoming a scourge of humanity. While everybody is acknowledging this, both PD (1) and AD (2) communities of clinician researchers and basic researchers are preparing to attack the problem fundamentally frequently unnoticed by the general neurology community. -
Paper of the MonthFeatured Slider
Paper of the month and Scientific Debate: A new hope for Alzheimer’s disease treatment with the PRIME study?
October 1, 2016For October 2016 we have selected: Sevigny J, Chiao P, Bussiere T, et al. The antibody aducanumab reduces Aβ plaques in Alzheimer’s disease. Nature 2016;537:50-56. Alzheimer’s disease (AD) is the most frequent neurodegenerative disorder. It is also extremely disabling with severe impact of the quality of life of patients and caregivers. The main pathological process is related to the toxic deposition of amyloid-β plaques and neurofibrillary tangles. No effective treatment is currently available to slow down the disease progression. -
Scientific CornerFeatured Slider
A ROUND TABLE discussion of the Paper of the Month with the EAN SCIENTIFIC PANEL on DEMENTIA AND COGNITIVE DISORDERS
October 1, 2016EANpages has the honor and the pleasure to introduce this virtual Round Table, composed by some members of the EAN Scientific Panel on Dementia and Cognitive Disorders, who are discussing the Paper of the Month, in addition to the comments of the Presidential Page. We thank the Panel for their enthusiastic participation and we invite all EAN members to participate with sending their comments. -
InterviewsFeatured Slider
Interview with Prof. David Nutt – President of the European Brain Council (EBC)
October 1, 2016David B. Vodušek (DV): EFNS has been a founding member of EBC, and its successor EAN continues to be an actively involved member society. Nevertheless, many of our readers would appreciate to hear your views on what is EBC, its mission and how it gets this accomplished? David Nutt (DN): The ultimate reason behind all EBC actions is to improve the condition of those living with brain disorders and to reduce prevalence of brain diseases all together. -
By Jose E. Martínez-Rodríguez
More than 9000 participants attended the 32nd Congress of the European Committee for the Treatment and Research in Multiple Sclerosis (ECTRIMS) and the 21st Annual Conference of Rehabilitation in MS in London from September 14th to17th.… Continue Reading -
Georgia (Georgian: საქართველო, Sakartvelo) is a country located at the intersection of Eastern Europe and West Asia, and generally considered to be part of the European continent. To the west it is bordered by the Black Sea, to the north and northeast by Russia, to the south by Turkey and Armenia, and by Azerbaijan to the southeast.
-
InterviewsFeatured Slider
Interview with Prof. Mansour Ndiaye President AFAN – African Academy of Neurology
September 1, 2016David Vodušek (DV): The AFAN, like the EAN, addresses and covers the neurological interest of a continent. Can you explain to the readers of the EANpages how was the AFAN created and why? Mansour Ndiaye (MN): Delegates from over 30 countries in Africa representing the interests of their national neurologic societies and associations met in Dakar, Senegal, over the weekend of August 29-30, 2015. -
Albania, officially the Republic of Albania (in Albanian: Republika e Shqipërisë), is situated in South-East Europe on the West of Balkan peninsula. It is bordered with Montenegro to the northwest, Kosovo to the northeast, Republic of Macedonia to the east and Greece to the south and southeast. Albania has a long coastal line facing the Adriatic Sea on the west and the Ionian Sea on the south and southwest.
-
InterviewsFeatured Slider
Interview with Prof. Kim Krogsgaard: Lundbeckfonden – Brain Prize
August 1, 2016David Vodušek (DV): The Lundbeckfonden Brain Prize is a very prestigious award. Can you illustrate to the EANpages readers how this prize came into existence and what is the scope of such a prize? Kim Krogsgaard (KK): In 2008 Lundbeckfonden’s board of trustees envisioned a large personal research prize within brain research.